Sigma Labs Announces Third Quarter 2014 Financial Results

Launched PrintRite3D® INSPECT™; Begun Marketing of 3D Printed Parts

SANTA FE, N.M., Nov. 14, 2014 /PRNewswire/ -- Sigma Labs, Inc. (OTCQB: SGLB) ("Sigma Labs" or the "Company"), a developer of advanced, in process, non-destructive quality inspection systems for metal-based additive manufacturing and other advanced manufacturing technologies, today announced financial results for the three and nine months ended September 30, 2014 and provided a business update.

Recent Highlights

  • Sigma Labs commercially launched its PrintRite3D® INSPECT™ quality assurance software and began actively marketing this unique software application to potential customers. Initial revenue is expected as early as the fourth quarter of 2014.   
  • The Company also took delivery of its first EOS M290 3D metal printer, now being integrated with Sigma Labs' PrintRite3D® quality assurance system for use in the production of precision metal parts. Sigma Labs is responding to requests for quotes and anticipates contract manufacturing orders over the next several months.
  • Sigma Labs recently received a contract from Honeywell Aerospace as part of a Defense Advanced Research Project Agency (DARPA) Phase II award. The DARPA program's goal is to develop an Integrated Computational Material Engineering (ICME) framework to accurately predict the properties of metal components produced using additive manufacturing.  
  • The Company was awarded an initial contract from Edison Welding Institute (EWI) as part of the previously-announced grant from the U.S. Department of Commerce's National Institute of Standards and Technology (NIST) for the development of in-process sensing and monitoring capabilities to ensure consistent quality in 3D printing. The contract will evaluate PrintRite3D® technology for monitoring and control applications.
  • The Company continues its previously-announced work with Materialise NV of Belgium, GE, Adurant Technologies, and other organizations to test, advance, and strengthen Sigma Labs' propriety IPQA® technology.

"Sigma Labs has had a very busy second half of 2014, and our path to commercialization and profitability continues to bear fruit," said Mark Cola, President and CEO. "Most notably, we officially launched our PrintRite3D® INSPECT™ quality assurance software and are currently demonstrating it to a number of potential customers eager to improve their 3D printing manufacturing. Our brand is clearly gaining traction in the marketplace through the many demonstration projects now underway, as well as our participation in various organizations including the Additive Manufacturing Consortium, part of the EWI. We won our first NIST contract with the EWI and were also awarded an order from Honeywell for a Phase II DARPA development project that should further validate our software and broaden the audience of potential customers.

"Both the EWI and Honeywell contracts will begin in the fourth quarter, and we expect to see initial product revenue from our INSPECT™ software this year as well.  In addition, we recently took delivery of  an EOS M290 machine and are already preparing for prototyping and small lot production of high-precision metal components. The Company will be able to offer contract manufacturing to a variety of industrial companies and further demonstrate our unique software applications to advance the speed, quality and consistency of 3D printing.

"We are on the right track to post significant top line growth next year tied to our product rollout strategy, which includes the expected launch of our PrintRite3D® DEFORM™ software early in 2015. The future looks bright, and we are certainly encouraged by what we see as growing demand for metal-based additive manufacturing applications going forward."

2014 Third Quarter and Year-to-Date Financial Results
Service revenue for the three and nine months ended September 30, 2014 was approximately $0.1 million and $0.3 million, respectively, versus approximately $0.3 million and $0.8 million for the same periods in 2013. The revenue decline year-over-year primarily reflects lower consulting revenue as the Company invests in the transition from services to product sales.

The Company reported a net loss for the three and nine months ended September 30, 2014 of approximately $0.5 million and $2.8 million, respectively, or $(0.00) per diluted share, versus a loss of approximately $0.2 million and $0.5 million, respectively, or $(0.00) per diluted share, for the same periods in 2013. The higher loss reflects lower revenue and increased general and administrative expense, payroll expense, non-cash compensation expense and warrant expense.

Investor Webcast
The Company will host an investor webcast, primarily to review the third quarter results and recent developments, on December 4, 2014 at 10:45 a.m. Eastern Time. Additional information about this event will be provided ahead of time.

About Sigma Labs, Inc.
Sigma Labs, Inc., through its wholly-owned subsidiary B6 Sigma, Inc., develops and engineers advanced, in-process, non-destructive quality inspection systems for commercial firms worldwide seeking productive solutions for metal-based additive manufacturing or 3D printing, and other advanced manufacturing technologies.  For more information please visit us at www.sigmalabsinc.com

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in our most recent annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.

 

Sigma Labs, Inc. and Subsidiaries

Unaudited Condensed Consolidated Statements of Operations

Three Months and Nine Months Ended September 30, 2014 and 2013




Three Months Ended



Nine Months Ended




September 30, 2014



September 30, 2013



September 30, 2014



September 30, 2013















INCOME

















   Services


$

92,449



$

280,831



$

322,091



$

753,080


          Total Revenue



92,449




280,831




322,091




753,080



















COST OF SERVICE REVENUE



36,326




159,367




176,954




395,846



















          GROSS PROFIT



56,123




121,464




145,137




357,234



















EXPENSES

















   General & Administration



296,085




181,562




712,264




463,911


   Payroll Expense



84,865




29,137




387,564




184,963


   Non-cash Stock Compensation



215,550




96,500




566,950




213,200


   Warrant Expense



-




-




1,283,333




-


          Total Expenses



596,500




307,199




2,950,111




862,074



















OTHER INCOME (EXPENSE)

















   Interest Income



939




308




2,721




319


         Total Other Income (Expense)



939




308




2,721




319



















INCOME (LOSS) BEFORE INCOME TAXES



(539,438)




(185,427)




(2,802,253)




(504,521)



















Current Income Tax Expense



-




-




-




-



















Deferred Income Tax Expense



-




-




-




-



















Net Income (Loss)


$

(539,438)



$

(185,427)



$

(2,802,253)



$

(504,521)



















Loss per Common Share - Basic and Diluted


$

(0.00)



$

(0.00)



$

(0.00)



$

(0.00)



















Weighted Average Number of Shares

















   Outstanding - Basic and Diluted



616,610,626




533,549,034




607,463,863




466,440,698


 

Sigma Labs, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

September 30, 2014 and December 31, 2013



September 30, 2014


December 31, 2013


(Unaudited)


(Audited)





ASSETS






   Current Assets






          Cash

$

3,682,533


$

992,448

          Accounts Receivable, net


48,007



303,445

          Inventory


49,264



1,167

          Prepaid Assets


17,791



25,074

   Total Current Assets


3,797,595



1,322,134













   Other Assets






          Furniture and Equipment, net


25,201



11,419

          Equipment Deposit


241,333



-

          Deferred Stock Offering Costs


108,380



17,426

          Intangible Assets, net


74,750



70,494

   Total Other Assets


449,664



99,339







TOTAL ASSETS

$

4,247,259


$

1,421,473







LIABILITIES AND STOCKHOLDERS' EQUITY






   Current Liabilities






          Accounts Payable

$

96,800


$

102,625

          Accrued Expenses


46,241



38,536

   Total Current Liabilities


143,041



141,161







TOTAL LIABILITIES


143,041



141,161







   Stockholders' Equity






         Preferred Stock, $0.001 par; 10,000,000 shares authorized;






                None issued and outstanding


-



-

         Common Stock, $0.001 par; 750,000,000 shares authorized;






                618,241,061 issued and 612,641,061






               outstanding at September 30, 2014 and






                559,766,061 issued and 556,816,061






               outstanding at December 31, 2013


618,241



559,766

          Additional Paid-In Capital


9,658,788



3,561,204

          Less Deferred Compensation






                5,600,000 and 2,950,000 common shares, respectively


(618,800)



(88,900)

          Retained Earnings (Deficit)


(5,554,011)



(2,751,758)

   Total Stockholders' Equity


4,104,218



1,280,312







TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

$

4,247,259


$

1,421,473

 

 

SOURCE Sigma Labs, Inc.